Alphabet, ExxonMobil and Toyota Motor headline today's top research reports, highlighting AI growth, energy cash generation and hybrid vehicle opportunities.

Top Research Reports for Alphabet, ExxonMobil & Toyota Motor

Key PointsThermo Fisher raised its 2026 organic revenue growth outlook to 4%.

Thermo Fisher Scientific: 3 Key Takeaways for Long-Term Investors

@media (max-width: 768px) {
                .image-container {
                    width: 100% !important;
                    float: none !important;
                    margin: 0 0 1rem 0 !important;
                }
            }
        



Image source: The Mo

Thermo Fisher (TMO) Q3 2026 Earnings Call Transcript

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the State Street Health Care Select Sector SPDR ETF (Symbol: XLV) where we have detected an approximate $530.5 million dollar inflow -- that's a 1.1% inc

State Street Health Care Select Sector SPDR ETF Experiences Big Inflow

(RTTNews) - Thermo Fisher Scientific Inc. (TMO) reported Wednesday that third-quarter revenue rose 9% to $12.14 billion from $11.12 billion a year earlier, while net income attributable to the company increased approximately by 6.2%.

Thermo Fisher Q3 Net Income Rises 6.2% As Revenue Climbs 9% 

(RTTNews) - Thermo Fisher Scientific (TMO) revealed earnings for its third quarter that Increases, from the same period last year

Thermo Fisher Scientific Profit Climbs In Q3 

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Thermo Fisher Scientific Inc. News